Drugs and Devices

FDA proposes new policy for some devices

The U.S. Food and Drug Administration (FDA) has proposed a new policy that reduces  premarket notification requirements related to devices that have had their safety and efficacy well proven, for example, blood clotting tests and common urine and blood tests. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares